Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli

Chelsie N. Geyer, Randal C. Fowler, James R. Johnson, Brian Johnston, Scott J. Weissman, Peter Hawkey, Nancy D. Hanson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: High levels of β-lactamase production can impact treatment with a β-lactam/β-lactamase inhibitor combination. Goals of this study were to: (i) compare the mRNA and protein levels of CTX-M-15- and CTX-M-14-producing Escherichia coli from 18 different STs and 10 different phylotypes; (ii) evaluate the mRNA half-lives and establish a role for chromosomal- and/or plasmid-encoded factors; and (iii) evaluate the zones of inhibition for piperacillin/tazobactam and ceftolozane/tazobactam. Methods: Disc diffusion was used to establish zone size. RNA analysis was accomplished using real-time RT-PCR and CTX-M protein levels were evaluated by immunoblotting. Clinical isolates, transformants and transconjugants were used to evaluate mRNA half-lives. Results: mRNA levels of CTX-M-15 were up to 165-fold higher compared with CTX-M-14. CTX-M-15 protein levels were 2-48-fold less than their respective transcript levels, while CTX-M-14 protein production was comparable to the observed transcript levels. Nineteen of 25 E. coli (76%) had extended CTX-M-15 mRNA half-lives of 5-15 min and 16 (100%) CTX-M-14 isolates had mRNA half-lives of

Original languageEnglish
Article numberdkv388
Pages (from-to)607-616
Number of pages10
JournalJournal of Antimicrobial Chemotherapy
Volume71
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Half-Life
Escherichia coli
Messenger RNA
Proteins
Lactams
Immunoblotting
Real-Time Polymerase Chain Reaction
Plasmids
RNA
galantide

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli. / Geyer, Chelsie N.; Fowler, Randal C.; Johnson, James R.; Johnston, Brian; Weissman, Scott J.; Hawkey, Peter; Hanson, Nancy D.

In: Journal of Antimicrobial Chemotherapy, Vol. 71, No. 3, dkv388, 01.03.2016, p. 607-616.

Research output: Contribution to journalArticle

Geyer, Chelsie N. ; Fowler, Randal C. ; Johnson, James R. ; Johnston, Brian ; Weissman, Scott J. ; Hawkey, Peter ; Hanson, Nancy D. / Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli. In: Journal of Antimicrobial Chemotherapy. 2016 ; Vol. 71, No. 3. pp. 607-616.
@article{5c70c7db27984819a3695b34c9f5bbd2,
title = "Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli",
abstract = "Objectives: High levels of β-lactamase production can impact treatment with a β-lactam/β-lactamase inhibitor combination. Goals of this study were to: (i) compare the mRNA and protein levels of CTX-M-15- and CTX-M-14-producing Escherichia coli from 18 different STs and 10 different phylotypes; (ii) evaluate the mRNA half-lives and establish a role for chromosomal- and/or plasmid-encoded factors; and (iii) evaluate the zones of inhibition for piperacillin/tazobactam and ceftolozane/tazobactam. Methods: Disc diffusion was used to establish zone size. RNA analysis was accomplished using real-time RT-PCR and CTX-M protein levels were evaluated by immunoblotting. Clinical isolates, transformants and transconjugants were used to evaluate mRNA half-lives. Results: mRNA levels of CTX-M-15 were up to 165-fold higher compared with CTX-M-14. CTX-M-15 protein levels were 2-48-fold less than their respective transcript levels, while CTX-M-14 protein production was comparable to the observed transcript levels. Nineteen of 25 E. coli (76{\%}) had extended CTX-M-15 mRNA half-lives of 5-15 min and 16 (100{\%}) CTX-M-14 isolates had mRNA half-lives of",
author = "Geyer, {Chelsie N.} and Fowler, {Randal C.} and Johnson, {James R.} and Brian Johnston and Weissman, {Scott J.} and Peter Hawkey and Hanson, {Nancy D.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1093/jac/dkv388",
language = "English",
volume = "71",
pages = "607--616",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli

AU - Geyer, Chelsie N.

AU - Fowler, Randal C.

AU - Johnson, James R.

AU - Johnston, Brian

AU - Weissman, Scott J.

AU - Hawkey, Peter

AU - Hanson, Nancy D.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objectives: High levels of β-lactamase production can impact treatment with a β-lactam/β-lactamase inhibitor combination. Goals of this study were to: (i) compare the mRNA and protein levels of CTX-M-15- and CTX-M-14-producing Escherichia coli from 18 different STs and 10 different phylotypes; (ii) evaluate the mRNA half-lives and establish a role for chromosomal- and/or plasmid-encoded factors; and (iii) evaluate the zones of inhibition for piperacillin/tazobactam and ceftolozane/tazobactam. Methods: Disc diffusion was used to establish zone size. RNA analysis was accomplished using real-time RT-PCR and CTX-M protein levels were evaluated by immunoblotting. Clinical isolates, transformants and transconjugants were used to evaluate mRNA half-lives. Results: mRNA levels of CTX-M-15 were up to 165-fold higher compared with CTX-M-14. CTX-M-15 protein levels were 2-48-fold less than their respective transcript levels, while CTX-M-14 protein production was comparable to the observed transcript levels. Nineteen of 25 E. coli (76%) had extended CTX-M-15 mRNA half-lives of 5-15 min and 16 (100%) CTX-M-14 isolates had mRNA half-lives of

AB - Objectives: High levels of β-lactamase production can impact treatment with a β-lactam/β-lactamase inhibitor combination. Goals of this study were to: (i) compare the mRNA and protein levels of CTX-M-15- and CTX-M-14-producing Escherichia coli from 18 different STs and 10 different phylotypes; (ii) evaluate the mRNA half-lives and establish a role for chromosomal- and/or plasmid-encoded factors; and (iii) evaluate the zones of inhibition for piperacillin/tazobactam and ceftolozane/tazobactam. Methods: Disc diffusion was used to establish zone size. RNA analysis was accomplished using real-time RT-PCR and CTX-M protein levels were evaluated by immunoblotting. Clinical isolates, transformants and transconjugants were used to evaluate mRNA half-lives. Results: mRNA levels of CTX-M-15 were up to 165-fold higher compared with CTX-M-14. CTX-M-15 protein levels were 2-48-fold less than their respective transcript levels, while CTX-M-14 protein production was comparable to the observed transcript levels. Nineteen of 25 E. coli (76%) had extended CTX-M-15 mRNA half-lives of 5-15 min and 16 (100%) CTX-M-14 isolates had mRNA half-lives of

UR - http://www.scopus.com/inward/record.url?scp=84960839666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960839666&partnerID=8YFLogxK

U2 - 10.1093/jac/dkv388

DO - 10.1093/jac/dkv388

M3 - Article

VL - 71

SP - 607

EP - 616

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 3

M1 - dkv388

ER -